Improving patient engagement in cancer trials
Part of Cancer clinical trials.
This study tests different ways to talk with patients about cancer clinical trials. If you are an adult with any type of cancer, your input could help researchers learn how to better inform and involve patients in future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older
- You have been diagnosed with any kind of cancer
- You are Black/African American, Asian/Asian American, White, or Hispanic
- You can speak English or Spanish
- You are able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses telemedicine (video or phone visits) to help older adults with cancer, especially those in underserved communities, get better care. If you're 65 or older and starting a new cancer treatment, you may be able to join from home in English, Spanish, or Chinese.
This trial asks patients about their interest in an integrative oncology program combining standard cancer care with complementary therapies like nutrition or acupuncture to improve well-being.
This study aims to help people learn more about cancer clinical trials and become more comfortable with the idea of joining one. It is open to adults connected to Karmanos Cancer Institute who want to learn and give their permission to participate.
This study tests a virtual community health educator to help cancer patients and their caregivers learn more about and join clinical trials. If you have had cancer or care for someone who has, this program might help you find trials that fit.
This study aims to identify and overcome barriers that prevent underserved groups from joining cancer trials. It involves working with patients, doctors, and hospitals to make clinical trials more accessible.
This study uses special cells grown in a lab to understand why some cancer treatments cause side effects. It may help researchers find ways to predict and prevent these side effects in the future.
Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.